EMVision Medical Devices Limited provided product development update. In contrast to every other imaging technology EMVision's electromagnetic (EM) imaging uses the interaction of the brain tissue with both the electric field and the magnetic fields that emanate from the EMV device's antennae. These electromagnetic fields are scattered and transmitted through the brain, and are received back by the EMVision device. These interactions provide a wealth of data which can be leveraged using EMVision's various signal processing algorithms. The EMVision Brain Scanner is a portable imaging device intended to provide diagnostic information obtained non-invasively from patients and without using ionizing radiation to rapidly distinguish between ischaemic and haemorrhagic strokes. In addition to this functionality, the EMVision team has recently developed two new potentially important techniques to further enhance diagnostic capability – anatomical dielectric maps and pulsatility. The Company is reviewing development options to advance these techniques. The EMVision technology has produced world leading, high fidelity images of brain structures, by mapping and analysing tissue permittivity, so opening a breakthrough for mobile imaging for clinician interpretation of the effect of anatomical structural changes, known as "dielectric maps". This will enable clinicians to see an image that uniquely visualises anatomical electrical properties, alongside diagnostic algorithms, yet is familiar in appearance to a CT or an MRI image. Whilst the visualisation may now feel familiar to a CT or MRI image, the intention for the EMVision technology remains the same - to be deployed where CT and MRI are not accessible or practical, by the bedside and in the future, in the prehospital setting. Dielectric maps produce an image of one of the electrical properties of brain tissue and this reflects the anatomy of the tissue; in almost real time it will allow clinicians to see the structure, better understand the impact of the stroke and watch what they are imaging. It is intended to be used in conjunction with existing diagnostic algorithms that display stroke localisation and classification. The dielectric maps are produced from the data acquired by the prototype brain scanner, take seconds to acquire and do not rely on any other imaging modality for anatomical templates. The EMVision dielectric map images have been indicatively verified against the findings of other modalities such as MRI and CT, with additional validation and verification work ongoing. Large Vessel Occlusion (LVO) is a blockage in one of the major arteries in the brain. Patients with ischaemic stroke due to large vessel occlusion will typically have severe neurological deficits and poor outcomes if not treated quickly. The EMVision team has identified a novel method of processing signal data known as "pulsatility", to potentially enable the earlier identification and triage of LVO patients. The technique may be used to measure blood flow through the brain, and therefore identify the degree of occlusion at the earliest stages as well as potentially localizing the extent of salvageable tissue and effect of reperfusion therapy. This may avoid devastating treatment delays, unnecessary disability and help minimize the associated downstream healthcare, insurer, and societal costs. This technique could be delivered at the point-of-care without the need of contrast agents or ionizing radiation. For individuals who have an acute ischemic stroke, the key to effective treatment is early reperfusion of ischaemic brain without causing adverse effects. The front-line therapy to achieve reperfusion is often intravenous thrombolytic therapy­ which is recommended in stroke treatment guidelines. Mechanical thrombectomy is a newer and highly effective additional treatment option for a sub-group of ischaemic stroke patients. Clinical trials around the world have demonstrated that earlier identification of and taking patients with Large Vessel Occlusions directly to the angiography suite for intervention significantly improves their 90-day functional outcomes. Thrombectomy is profoundly time sensitive and only available at these comprehensive stroke centres. The pulsatility technique may enable rapid triage of these patients directly to the angiography suite at comprehensive stroke centres for earlier intervention.